Cyclopharm Limited Stock
Stocks
CYC
AU000000CYC5
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Australian S.E.
09:10:27 04/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.5200 AUD | +1.96% |
|
+0.97% | -46.94% |
| 09-02 | Cyclopharm Limited, H1 2026 Earnings Call, Sep 02, 2026 | |
| 08-24 | Cyclopharm Limited Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 65.38M 47.13M 40.55M 38.16M 34.86M 65.2M 4.45B 451M 175M 2.28B 177M 173M 7.35B | P/E 2026 * |
-3.79x | P/E 2027 * | -5.94x |
|---|---|---|---|---|---|
| Enterprise Value | 65.38M 47.13M 40.55M 38.16M 34.86M 65.2M 4.45B 451M 175M 2.28B 177M 173M 7.35B | EV / Sales 2026 * |
1.76x | EV / Sales 2027 * | 1.39x |
| Free-Float |
51.17% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Cyclopharm Limited
| 1 day | +1.96% | ||
| 1 week | +0.97% | ||
| Current month | -5.45% | ||
| 1 month | -7.14% | ||
| 3 months | -17.46% | ||
| 6 months | -31.13% | ||
| Current year | -46.94% |
| 1 week | 0.5 |  | 0.55 |
| 1 month | 0.46 | | 0.59 |
| Current year | 0.45 | | 1.29 |
| 1 year | 0.45 | | 1.29 |
| 3 years | 0.45 | | 3.15 |
| 5 years | 0.45 | | 3.15 |
| 10 years | 0.45 | | 3.45 |
| Manager | Title | Age | Since |
|---|---|---|---|
James McBrayer
CEO | Chief Executive Officer | 60 | 21/10/2009 |
Jason Smith
DFI | Director of Finance/CFO | - | 26/02/2024 |
Mathew Farag
COO | Chief Operating Officer | - | 01/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Dianne Angus
BRD | Director/Board Member | 65 | 10/08/2021 |
James McBrayer
BRD | Director/Board Member | 60 | 03/06/2008 |
Kevin Barrow
BRD | Director/Board Member | - | 01/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/12/26 A | Buy | Director | 21,052 | 0.0175% | ||
| 3/12/26 A | Buy | Director | 5,263 | 0.0044% | ||
| 3/12/26 A | Buy | Director | 21,052 | 0.0175% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.96% | +0.97% | -37.35% | -78.33% | 47.13M | |
| -0.75% | -1.35% | +25.39% | +10.15% | 227B | |
| -1.60% | -3.89% | +4.34% | -21.81% | 146B | |
| -0.85% | -1.58% | -19.32% | +18.13% | 130B | |
| +1.81% | +2.05% | -55.45% | -10.85% | 69.27B | |
| +0.13% | -0.34% | +11.04% | +17.70% | 51.82B | |
| +0.49% | -1.32% | -17.27% | -14.42% | 50.45B | |
| +0.59% | -1.94% | +17.42% | +23.75% | 42.53B | |
| -1.01% | -1.28% | +36.60% | +45.68% | 40.22B | |
| -1.55% | +1.22% | +123.40% | +29.54% | 32.95B | |
| Average | -0.02% | -1.31% | +8.88% | +1.95% | 78.98B | |
| Weighted average by Cap. | -0.44% | -1.55% | +7.64% | +5.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.2M 26.81M 23.07M 21.71M 19.83M 37.1M 2.53B 257M 99.55M 1.3B 101M 98.5M 4.18B | 47.2M 34.02M 29.28M 27.55M 25.16M 47.07M 3.21B 325M 126M 1.65B 128M 125M 5.31B |
| Net income | -17.4M -12.54M -10.79M -10.15M -9.28M -17.35M -1.18B -120M -46.56M -608M -47.1M -46.07M -1.96B | -12.4M -8.94M -7.69M -7.24M -6.61M -12.37M -844M -85.51M -33.18M -433M -33.56M -32.83M -1.39B |
| Net Debt | - | - |
Employees
104
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | A$0.5200 | +1.96% | 115,567 |
| 03/09/26 | A$0.5100 | +0.99% | 2,300 |
| 02/09/26 | A$0.5050 | -0.98% | 36,428 |
| 01/09/26 | A$0.5100 | -7.27% | 48,852 |
| 31/08/26 | A$0.5500 | +6.80% | 23,095 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3748USD
Average target price
0.7170USD
Spread / Average Target
+91.29%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CYC Stock
Select your edition
All financial news and data tailored to specific country editions
